The core product offerings of Alembic Pharmaceuticals include a robust mix of leading prescription pharmaceutical brands across diverse therapeutic segments. Their key revenue drivers historically feature prominent anti-infective formulations, cough remedies, and chronic therapy drugs covering cardiology, diabetology, neurology, and orthopedics. Additionally, the company produces a wide array of generic active pharmaceutical ingredients and finished dosage products tailored for highly regulated international markets like the United States and Europe. Their strong domestic brand equity and expanding global generic pipeline form the foundation of their commercial success.